ATX.AX
Amplia Therapeutics Limited$0.11
Jun 15, 2026
Market cap
$59.03M
52w range
—
P / E
—
EPS · FY 2026
$-0.02
Volume
—
Revenue · FY 2026
$0
Explain this page
Arphra AIPlain-English read on Amplia Therapeutics Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →ATX.AX
0.11-12.00%H 0.28L 0.10MA50 0.15MA200 —Avg vol 4.7M
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Communication Services+1.85%
- Utilities+1.35%
- Consumer Cyclical+0.30%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Basic Materials-0.66%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Biotechnology+0.28%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Grocery Stores-4.35%
- Financial - Mortgages+4.08%
- Broadcasting+4.00%
- Computer Hardware-3.67%
- Internet Content & Information+3.58%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for ATX.AX.
Peers
No peer list available for ATX.AX.
Total assets
$41.44M
Total debt
$341.11K
Cash & equiv
$27.85M
Operating CF
-$8.73M
Free cash flow
-$8.77M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $0 | -$13.18M | -$7.71M | $-0.02 | — |